Laura Stopforth
University of KwaZulu-Natal
19 Papers
2 Citations
Laura Stopforth is an academic researcher from University of KwaZulu-Natal. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 4, co-authored 9 publications. Previous affiliations of Laura Stopforth include University of the Witwatersrand.
Chat about Author
Papers
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy.
Daniel S. O’Neil,Sarah Nietz,Ines Buccimazza,Ines Buccimazza,Urishka Singh,Urishka Singh,Sharon Čačala,Sharon Čačala,Laura Stopforth,Laura Stopforth,Maureen Joffe,Judith S. Jacobson,Alfred I. Neugut,Katherine D. Crew,Paul Ruff,Herbert Cubasch +15 more
TL;DR: The clinical and sociodemographic factors associated with receiving neoadjuvant chemotherapy among patients from a previously existing cohort: women enrolled in the prospective South African Breast Cancer and HIV Outcomes study are analyzed.
17
The multimorbidity profile of South African women newly diagnosed with breast cancer.
Oluwatosin Ayeni,Shane A. Norris,Maureen Joffe,Herbert Cubasch,Sarah Nietz,Ines Buccimazza,Urishka Singh,Sharon Čačala,Laura Stopforth,Wenlong Carl Chen,Wenlong Carl Chen,Valerie McCormack,Daniel S. O’Neil,Judith S. Jacobson,Alfred I. Neugut,Paul Ruff,Lisa K. Micklesfield +16 more
TL;DR: It is suggested that multimorbidity had a significant impact on treatment received in those with early‐stage disease and there is need to understand the impact of multimOrbidity on breast cancer outcomes.
17
Breast Cancer Care Quality in South Africa's Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures.
Daniel S. O’Neil,Wenlong Carl Chen,Oluwatosin Ayeni,Sarah Nietz,Ines Buccimazza,Ines Buccimazza,Urishka Singh,Urishka Singh,Sharon Čačala,Sharon Čačala,Laura Stopforth,Laura Stopforth,Maureen Joffe,Katherine D. Crew,Judith S. Jacobson,Alfred I. Neugut,Paul Ruff,Herbert Cubasch +17 more
TL;DR: More timely delivery of chemotherapy, radiotherapy, and endocrine therapy is needed in South Africa, particularly for women living > 20 km from the hospital or not speaking English.
16
Impact of HIV infection on survival among women with stage I‐III breast cancer: Results from the South African breast cancer and HIV outcomes study
Oluwatosin Ayeni,Daniel S. O’Neil,Yoanna Pumpalova,Wenlong C. Chen,Sarah Nietz,Boitumelo P. Phakathi,I. Buccimazza,Sharon Čačala,Laura Stopforth,H. Farrow,Witness Mapanga,Maureen Joffe,Tobias Chirwa,Valerie McCormack,Judith S. Jacobson,Katherine D. Crew,Alfred I. Neugut,Paul Ruff,Herbert Cubasch +18 more
TL;DR: Because receipt of antiretroviral therapy has become widespread, WLWH is surviving long enough to develop BC; more research is needed on the causes of their poor survival.
15
A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection.
Sarah Nietz,Daniel S. O’Neil,Oluwatosin Ayeni,Wenlong Carl Chen,Wenlong Carl Chen,Maureen Joffe,Judith S. Jacobson,Alfred I. Neugut,Alfred I. Neugut,Paul Ruff,Witness Mapanga,Ines Buccimazza,Urishka Singh,Sharon Čačala,Laura Stopforth,Boitumelo Phakathi,Tobias Chirwa,Herbert Cubasch +17 more
TL;DR: WLWH were less like to achieve pCR following NACT for BC than women without HIV, which reduced response to systemic therapy may contribute to the poorer BC outcomes seen in WLWH.
13